A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection Publication A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection This study synthesizes data from a large body of clinical trials to evaluate rates of…Certara2025 年 12 月 18 日
Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation Publication Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…Certara2025 年 11 月 5 日
Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Publication Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…Certara2025 年 10 月 31 日
MBMA vs. Meta-Analysis: Quick Comparison Guide Guide MBMA vs. Meta-Analysis: Quick Comparison Guide Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…Certara2025 年 10 月 8 日
Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials Blog 基于模型的荟萃分析(MBMA)在 GSK 的应用:对战略和临床试验的实际影响 GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…Certara2025 年 7 月 31 日
5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address Blog 5 大临床开发挑战 — 基于模型的荟萃分析(MBMA)助力应对 2025 年 6 月 30 日 Drug development is increasingly defined by its complexity. Teams must navigate rising…Certara2025 年 6 月 30 日
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara On-Demand Webinar 从数据到决策:基于模型的荟萃分析(MBMA)与 GSK 和 Certara 真实世界影响 Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…Certara2025 年 6 月 18 日
A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition Publication 基于转化模型的荟萃分析,预测与血清素再摄取转运体抑制相关的震颤发生率 The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…Certara2025 年 4 月 30 日
Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications On-Demand Webinar 相对治疗效果和绝对结局的基于模型的荟萃分析:聚焦概念与应用 Vice President, MBMA Capability Lead, Certara Drug Development Solutions Matt advances the integration of published…Certara2025 年 4 月 10 日
Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar] On-Demand Webinar Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar] Vice President, Quantitative Science Services, Certara Matt advances the integration of published clinical outcomes data…Certara2025 年 4 月 3 日